Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BOOM-IBD2 Pivotal Clinical Trial

NCT: NCT06571669 · RECRUITING

NCT IDNCT06571669
StatusRECRUITING
Start Date2025-01-31
Completion2027-11-30

Brief Summary

Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tailbone. It is placed during a same-day procedure.

Frequently Asked Questions

What is BOOM-IBD2 Pivotal Clinical Trial?

BOOM-IBD2 Pivotal Clinical Trial is a clinical trial registered under NCT06571669. Current status: RECRUITING.

What is the status of NCT06571669?

The current status of NCT06571669 (BOOM-IBD2 Pivotal Clinical Trial) is: RECRUITING.

When did BOOM-IBD2 Pivotal Clinical Trial start?

BOOM-IBD2 Pivotal Clinical Trial started on 2025-01-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑